Molecular Therapy

TABLE 1

FROM:

Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow

Caroline J Breitbach, Jennifer M Paterson, Chantal G Lemay, Theresa J Falls, Allison McGuire, Kelley A Parato, David F Stojdl, Manijeh Daneshmand, Kelly Speth, David Kirn, J Andrea McCart, Harold Atkins and John C Bell

BACK TO ARTICLE

Table 1. Genes up-regulated in CT-26 tumor 24 hours after infection with VSV, as compared with genes expressed in tumor treated with UV-inactivated VSV

Category and probe setFold increasea Description
Chemotaxis
NM008176127Chemokine (C-X-C motif) ligand 1
NM00911486S100 calcium binding protein A9 (calgranulin B)
NM01365338Chemokine (C-C motif) ligand 5
BC02439237Chemokine (C-X-C motif) ligand 5
NM01365029S100 calcium binding protein A8 (calgranulin A)
NM01746621Chemokine (C-C motif) receptor-like 2
NM00914014Chemokine (C-X-C motif) ligand 2
NM01133314Chemokine (C-C motif) ligand 2
NM01133711Chemokine (C-C motif) ligand 3
NM0212749Chemokine (C-X-C motif) ligand 10
NM0136544Chemokine (C-C motif) ligand 7
NM0194944Chemokine (C-X-C motif) ligand 11
Inflammation
BC020275624b Neutrophil gelatinase associated lipocalin 1
NM010510294Interferon-beta, fibroblast
NM03116852Interleukin 6
NP03409940b Colony stimulating factor (granulocyte-macrophage)
NM01119835Prostaglandin-endoperoxide synthetase 2 (COX-2)
AB18589618Tumor necrosis factor alpha
NM00977812Complement component 3

  Abbreviations: COX, cyclooxygenase; UV, ultraviolet; VSV, vesicular stomatitis virus.

a Values taken from microarray experiment, quantitative real-time polymerase chain reaction analysis shown in Figure S3. bSignals for these genes were absent in UV-inactivated sample. Changes in up-regulation, expressed as multiples, were calculated using an arbitrary signal value of 600 for the UV-inactivated sample.

BACK TO ARTICLE